How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects.
about
Smoking and diabetes in Chinese menA retrospective cohort study on the risk of stroke in relation to a priori health knowledge level among people with type 2 diabetes mellitus in Taiwan.Smoking and arterial stiffness in youth with type 1 diabetes: the SEARCH Cardiovascular Disease Study.Perspectives on vascular biology and diabetes.Lessons for atherosclerosis research from tuberculosis and peptic ulcer.New concepts in diabetes mellitus. II: Complications.A six-year follow-up study of smoking habits and microvascular complications in young adults with type 1 diabetes.The St Vincent Task Force for diabetes: report of the cardiovascular disease subgroupWaist circumference as a measure for indicating need for weight management.Cigarette smoking: an important renal risk factor - far beyond carcinogenesis.Hyperhomocysteinemia and lower extremity wounds.Smoking and hypertension.Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.Hyperinsulinaemia, insulin resistance, microalbuminuria and the risk of coronary heart disease.Lipids, thrombosis and cardiovascular disease in diabetes.Design of cost-effective packages of care for non-insulin-dependent diabetes mellitus. Defining the information needs.Assessing coronary risk.Which diabetic patients should be taking aspirin?Low-density lipoprotein apheresis: clinical results with different methods.Teaching patients to monitor their risk factors retards the progression of vascular complications in high-risk patients with Type 2 diabetes mellitus--a randomized prospective study.Cigarette smoking: an important renal risk factor – far beyond carcinogenesis.Smoking cessation in patients with diabetes mellitus: results from a controlled study of an intervention programme in primary healthcare in Sweden.Cardiac disease in diabetic end-stage renal disease.Mortality mapping in Hong Kong, 1979-83 and 1984-88: the patterns of major non-malignant diseases.Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality.Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.LDL-apheresis: technical and clinical aspects.
P2860
Q28361277-2B105E27-C3C2-47EE-9591-57C1DFC38683Q33716777-075F8C5D-80E9-41B6-B3DD-B7BB2D435EB4Q33819214-37385AF0-B01B-468F-90BC-FCD5392417B0Q34161037-B8E94F9A-860E-4426-B94E-C79122421165Q34278447-E297A266-4916-4227-8527-A88180C5CEF3Q36679058-7658993A-C83E-4432-8C6D-D902869A0CBDQ36727827-F03B4814-DABA-4ED1-A6B4-BC5FF9B5093BQ36834253-833D9254-A626-4321-9625-36FA0458C6A6Q36904283-1321B36B-DA24-4EA8-8504-31EBEFD314A8Q37165278-D66C22E9-934B-4923-93E9-D08481510A24Q37256090-CF51639A-4BB2-4FEA-8027-41AB842FAD6DQ40794682-43BC1747-D1F0-46D3-A0B1-A37813054AEAQ40884232-E9497481-20EF-4CBA-9CF3-CC4E2D1076B4Q41250377-F2C3B1DF-554D-4F67-9EE7-71440D885412Q41486255-733A8966-9131-45E1-B0A7-1C6F3C177294Q41600402-B85D3431-F425-4B26-97CC-1073337B5700Q42872048-53F455AE-B3BD-4763-A7F0-34B9EE3F70B1Q42913738-59ACA1CF-877D-439B-A893-192859EC2A53Q43905985-AE2795F8-D409-4A81-9C46-975E6F72D19AQ44004490-0DFE43D1-102B-4706-BC9D-5E63E984DBB3Q46661747-EB94C6A2-87CD-4D17-AC69-F2EB7B71C071Q48447362-29F8F673-9DAC-4803-AE60-AA137A7D5357Q50920613-56C362C5-6A8F-4E56-9E5B-2FCF7058A5E7Q50973104-CCE60B04-6DAD-49CB-ACD6-35D6B6973828Q50999247-72B4734D-F2A4-443D-B676-F9B0A31A9A02Q51629611-8D205277-838C-4485-BFA8-B85587346D2DQ55652029-22244CD6-0C62-4C39-B8AA-783D2320C149
P2860
How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects.
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
How can we best prolong life? ...... iabetic and diabetic subjects.
@ast
How can we best prolong life? ...... iabetic and diabetic subjects.
@en
type
label
How can we best prolong life? ...... iabetic and diabetic subjects.
@ast
How can we best prolong life? ...... iabetic and diabetic subjects.
@en
prefLabel
How can we best prolong life? ...... iabetic and diabetic subjects.
@ast
How can we best prolong life? ...... iabetic and diabetic subjects.
@en
P2860
P1433
P1476
How can we best prolong life? ...... iabetic and diabetic subjects.
@en
P2093
P2860
P304
P356
10.1136/BMJ.306.6888.1313
P407
P577
1993-05-01T00:00:00Z